These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 8209669)

  • 41. [Danazol and its effect on bone and lipid metabolism in patients with endometriosis].
    Duque G; Bianchi M; Fernández C; Arteaga E
    Rev Chil Obstet Ginecol; 1995; 60(1):34-7. PubMed ID: 8525034
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Drug therapy of endometriosis].
    Wenzl R; Jirecek S; Huber J
    Wien Med Wochenschr; 1999; 149(13):372-3, 376. PubMed ID: 10568019
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Medical treatment of endometriosis.
    Garcia-Velasco JA; Quea G
    Minerva Ginecol; 2005 Jun; 57(3):249-55. PubMed ID: 16166934
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [GnRH-agonists in the therapy of endometriosis].
    Hoffmann G; Spitz J; Behrens R
    Ther Umsch; 1990 Dec; 47(12):937-44. PubMed ID: 2128966
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Medical management of endometriosis: a systematic review.
    Schroder AK; Diedrich K; Ludwig M
    IDrugs; 2004 May; 7(5):451-63. PubMed ID: 15154107
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nafarelin: a new medical therapy for endometriosis.
    Henzl MR; Monroe SE
    Prog Clin Biol Res; 1990; 323():343-55. PubMed ID: 2137620
    [No Abstract]   [Full Text] [Related]  

  • 47. Gonadotropin-releasing hormone agonists: strategies for managing the hypoestrogenic effects of therapy.
    Judd HL
    Am J Obstet Gynecol; 1992 Feb; 166(2):752-6. PubMed ID: 1531578
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparison of progestogens or oral contraceptives and gonadotropin-releasing hormone agonists for the treatment of endometriosis: a systematic review.
    Jeng CJ; Chuang L; Shen J
    Expert Opin Pharmacother; 2014 Apr; 15(6):767-73. PubMed ID: 24588662
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Guidelines for the management of painful endometriosis].
    Roman H; Puscasiu L
    Chirurgia (Bucur); 2008; 103(3):265-74. PubMed ID: 18717274
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Bone loss induced by GnRH agonist treatment].
    Onoe Y; Ohta H
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():702-5. PubMed ID: 15035212
    [No Abstract]   [Full Text] [Related]  

  • 51. Zoladex (goserelin acetate implant) in the treatment of endometriosis: a randomized comparison with danazol. The Zoladex Endometriosis Study Group.
    Rock JA; Truglia JA; Caplan RJ
    Obstet Gynecol; 1993 Aug; 82(2):198-205. PubMed ID: 8336864
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Endometriosis: clinical, histological and morphometric findings before and after Gn-RH agonist therapy].
    Ruwe M; Donhuijsen K; Regidor PA; Leder LD; Schindler AE
    Zentralbl Gynakol; 1998; 120(8):391-8. PubMed ID: 9757546
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Progestagens and anti-progestagens for pain associated with endometriosis.
    Brown J; Kives S; Akhtar M
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD002122. PubMed ID: 22419284
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A randomized comparative study of the effect of leuprorelin acetate depot and danazol in the treatment of endometriosis.
    Chang SP; Ng HT
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Jun; 57(6):431-7. PubMed ID: 8803306
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of hormonal contraception on bone mineral density after 24 months of use.
    Berenson AB; Breitkopf CR; Grady JJ; Rickert VI; Thomas A
    Obstet Gynecol; 2004 May; 103(5 Pt 1):899-906. PubMed ID: 15121563
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnosis and treatment of endometriosis. A review.
    Scarselli G; Rizzello F; Cammilli F; Ginocchini L; Coccia ME
    Minerva Ginecol; 2005 Feb; 57(1):55-78. PubMed ID: 15758866
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pulmonary endometriosis: conservative treatment with GnRH agonists.
    Espaulella J; Armengol J; Bella F; Lain JM; Calaf J
    Obstet Gynecol; 1991 Sep; 78(3 Pt 2):535-7. PubMed ID: 1831251
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of pulmonary endometriosis with a long-acting GnRH agonist.
    Seltzer VL; Benjamin F
    Obstet Gynecol; 1990 Nov; 76(5 Pt 2):929-31. PubMed ID: 2120647
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Managing the misplaced: approach to endometriosis.
    Jackson B; Telner DE
    Can Fam Physician; 2006 Nov; 52(11):1420-4. PubMed ID: 17279199
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antiprogestin and/or gonadotropin-releasing hormone agonist for endometriosis treatment and bone maintenance: a 1-year primate study.
    Grow DR; Williams RF; Hsiu JG; Hodgen GD
    J Clin Endocrinol Metab; 1996 May; 81(5):1933-9. PubMed ID: 8626860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.